Impact Factor 4.300

The world's most-cited Neurosciences journals

Original Research ARTICLE Provisionally accepted The full-text will be published soon. Notify me

Front. Cell. Neurosci. | doi: 10.3389/fncel.2018.00453

Mineralocorticoid Antagonist Improves Glucocorticoid Receptor Signaling and Dexamethasone Analgesia in an Animal Model of Low Back Pain

 Shaimaa Ibrahim1, Wenrui Xie1,  Judith A. Strong1, Raquel Tonello1,  Temugin Berta1 and  Jun-Ming Zhang1*
  • 1University of Cincinnati, United States

Low back pain, a leading cause of disability, is commonly treated by epidural steroid injections that target the anti-inflammatory glucocorticoid receptor (GR). However, their efficacy has been controversial. All currently used epidural steroids also activate the pro-inflammatory mineralocorticoid receptor (MR) with significant potency. Local inflammation of the dorsal root ganglia (DRG), a rat model of low back pain was used. This model causes static and dynamic mechanical allodynia, cold allodynia, and guarding behavior (a measure of spontaneous pain), and activates the MR, with pro-nociceptive effects. In this study, effects of local dexamethasone (a glucocorticoid used in epidural injections), and eplerenone (a second generation, more selective MR antagonist) applied to the DRG at the time of inflammation were examined. Mechanical and spontaneous pain behaviors were more effectively reduced by the combination of dexamethasone and eplerenone than by either alone. The combination of steroids was particularly effective than dexamethasone alone or the model alone (3-fold improvement for mechanical allodynia) at later times (day 14). Immunohistochemical analysis of the GR in the DRG showed that the receptor was expressed in neurons of all size classes, and in non-neuronal cells including satellite glia. The GR immunoreactivity was downregulated by DRG inflammation (48%) starting on day 1, consistent with the reduction of GR (57%) observed by Western blot, when compared to control animals. On day 14, the combination of dexamethasone and eplerenone resulted in rescue of GR immunoreactivity that was not seen with dexamethasone alone. The results suggest that eplerenone may enhance the effectiveness of clinically used epidural steroid injections, in part by enhancing the availability of the GR. Thus, the glucocorticoid-mineralocorticoid interactions may limit the effectiveness of epidural steroids through the regulation of the GR in the dorsal root ganglia.

Keywords: Pain, Dorsal root ganglion (DRG), mineralocorticoid receptor, Glucocorticoid receptor, Inflammation

Received: 21 Sep 2018; Accepted: 09 Nov 2018.

Edited by:

Marco Martina, Northwestern University, United States

Reviewed by:

Hee Kee Kim, University of Texas MD Anderson Cancer Center, United States
Parisa Gazerani, Aalborg University, Denmark  

Copyright: © 2018 Ibrahim, Xie, Strong, Tonello, Berta and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: MD. Jun-Ming Zhang, University of Cincinnati, Cincinnati, United States, jun-ming.zhang@uc.edu